quick one im at 2.4 and the appetite effect is stronger than i expected, normal
#retatrutide 2026-06-06
- clothes_size_cass — quick one im at 2.4 and the appetite effect is stronger than i expected, normal 17:50
- lisbon_lot — anyone gone above 2.4 and what changed 18:28
- clothes_size_cass — research use only is on every vial and i treat it as exactly that, nobody here is prescribing, take that with a pinch of salt 18:40
- lisbon_lot — quick one Medutest came back 97.4 on one lot and 98.1 on the next from the same Homopeptide, both fine 19:03
TRIUMPH is the phase 3 programme, thats the name to search rather than the molecule
came off at 32 weeks because my resting rate stayed elevated and i didnt like it
is the GI worse than tirzepatide or about the same
nobody should read my log as a plan, im recording what i did and thats all it is, from memory
TRIUMPH is phase 3
how long before people saw the first change at 2.5
anyone gone above 2.4 and what changed
energy expenditure isnt something i could feel, though my sleep tracker disagreed with me
the honest position is this has less human evidence behind it than anything else discussed here, anyway
research use only is on every vial and i treat it as exactly that, nobody here is prescribing, take that with a pinch of salt
blood pressure stayed flat for me while heart rate moved, which i didnt expect
smaller steps here
phase 2 only
quick one Medutest came back 97.4 on one lot and 98.1 on the next from the same Homopeptide, both fine
there is no long term safety data, phase 2 and an ongoing phase 3 programme is what exists
no long term data
did the phase 2 result actually come in higher than the tirzepatide numbers
while im here back after 2 months, has anything actually been published since
watching my heart rate
i went up too fast, got a fortnight of nothing but nausea, and dropped back two steps
triple agonist meaning GLP-1, GIP and glucagon, have i got that right
i said 6 months ago that my heart rate had settled and it has stayed settled since, anyway
the glucagon arm is the mechanistic story for extra energy expenditure and its still a story to me
whats a sensible starting point, im seeing everything from 0.5 to 2
triple agonist yeah
anyone logging resting heart rate on this
did the phase 2 plateau or was it still moving at the end
low and slow
triple agonist, GLP-1 and GIP and glucagon. the glucagon arm is the part with no long history
stopped for 10 months and restarted at half my old dose, the ramp was easier second time
held mine ages
held at 12 for 24 months and it never plateaued for me, which i cant explain
research use only
no idea whether the heart rate settles for everyone, mine did and one log isnt data
glucagon is the new bit
while im here GI was about the same as tirzepatide for me, the difference was how fast it arrived
phase 2 doses are published and theyre not far off what people here run, coincidence rather than plan
logging rhr daily
update on the earlier thing is there any long term safety data at all or is it phase 2 and hope
does the energy expenditure claim show up as anything you can feel
follow up my resting heart rate is up about 8 bpm, did that settle for anyone
did anyone come off because of the heart rate